XML 253 R121.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investments in joint ventures - Summarized Financial Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Disclosure of joint ventures [line items]      
Sales and other operating revenues $ 244,582 $ 186,606 $ 225,982
Profit (loss) before interest and taxation 9,474 (430) (7,918)
Finance costs [1] 2,074 1,675 1,347
Profit (loss) before taxation 7,180 (2,295) (9,571)
Taxation [1] 3,712 (2,467) (3,171)
Profit (loss) for the year [2],[3] 3,468 172 (6,400)
Other comprehensive income [2],[3] 5,016 (988) (1,818)
Total comprehensive income [2],[3] 8,484 (816) (8,218)
Non-current assets 201,547 195,503  
Current assets 74,968 67,813  
Total assets 276,515 263,316  
Current liabilities 64,726 58,354  
Non-current liabilities 111,385 108,119  
Total liabilities 176,111 166,473  
Net assets 100,404 96,843  
Investments in joint ventures accounted for using equity method 7,994 8,609  
BP's share of impairment losses recognized by joint ventures 1,216 (1,664) 1,909
Joint ventures      
Disclosure of joint ventures [line items]      
Sales and other operating revenues 11,380 10,081 9,588
Profit (loss) before interest and taxation 1,394 1,612 785
Finance costs 100 156 188
Profit (loss) before taxation 1,294 1,456 597
Taxation 117 490 625
Profit (loss) for the year 1,177 966 (28)
Other comprehensive income 8 5 (1)
Total comprehensive income 1,185 971 (29)
Non-current assets 10,139 10,874  
Current assets 2,419 3,257  
Total assets 12,558 14,131  
Current liabilities 1,687 2,087  
Non-current liabilities 2,927 3,520  
Total liabilities 4,614 5,607  
Net assets 7,944 8,524  
Loans made by group companies to joint ventures 50 85  
Investments in joint ventures accounted for using equity method $ 7,994 $ 8,609  
BP's share of impairment losses recognized by joint ventures     $ 711
[1] See Note 2 for information on the impact of the Gulf of Mexico oil spill on these income statement line items.
[2] See Note 30 for further information.
[3] See Note 30 for further information.